Gsk Autoinjector


Combined with:

Sumatriptan Succinate

Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 67.7%
Migraine 25.0%
Product Used For Unknown Indication 2.6%
Anxiety 0.7%
Headache 0.7%
Migraine Prophylaxis 0.5%
Diabetes Mellitus 0.4%
Back Pain 0.2%
Breakthrough Pain 0.2%
Bursitis 0.2%
Depression 0.2%
Fatigue 0.2%
Hypersensitivity 0.2%
Ill-defined Disorder 0.2%
Insomnia 0.2%
Medical Diet 0.2%
Multiple Allergies 0.2%
Muscle Spasms 0.2%
Oedema 0.2%
Seasonal Allergy 0.2%
Product Quality Issue 87.2%
Drug Ineffective 2.3%
Device Malfunction 1.1%
Injection Site Pain 1.1%
Therapeutic Response Decreased 1.1%
Drug Administration Error 0.8%
Expired Drug Administered 0.8%
Migraine 0.8%
Pharmaceutical Product Complaint 0.8%
Adverse Drug Reaction 0.4%
Application Site Swelling 0.4%
Arthropathy 0.4%
Asthenopia 0.4%
Dysuria 0.4%
Erythema 0.4%
Foreign Body 0.4%
Gallbladder Operation 0.4%
Hospitalisation 0.4%
Hypersensitivity 0.4%
Injection Site Haematoma 0.4%

Drug Data